Cargando…

Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a genetically determined myocardial disease that constitutes the main cause of sudden cardiac death (SCD) in young athletes. Apical HCM (ApHCM) represents a complex subset of patients, whose risk of SCD seems not negligible. Most applied scores likely...

Descripción completa

Detalles Bibliográficos
Autores principales: Files Flores, Rui, Mané, Fernando, Antunes, Nuno, Pereira, Vítor Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649509/
https://www.ncbi.nlm.nih.gov/pubmed/33204988
http://dx.doi.org/10.1093/ehjcr/ytaa316
_version_ 1783607343937748992
author Files Flores, Rui
Mané, Fernando
Antunes, Nuno
Pereira, Vítor Hugo
author_facet Files Flores, Rui
Mané, Fernando
Antunes, Nuno
Pereira, Vítor Hugo
author_sort Files Flores, Rui
collection PubMed
description BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a genetically determined myocardial disease that constitutes the main cause of sudden cardiac death (SCD) in young athletes. Apical HCM (ApHCM) represents a complex subset of patients, whose risk of SCD seems not negligible. Most applied scores likely underestimate the risk of heart events in this subset of patients. CASE SUMMARY: We report the case of a 55-year-old man who was admitted in the emergency department after an episode of aborted sudden death due to ventricular fibrillation. The electrocardiogram made at admission was noted for atrial fibrillation and a new-onset left bundle branch block. Emergency coronary angiography was normal. The electrocardiogram was repeated and showed symmetrical and profound inversion of T waves in the lateral leads. Transthoracic echocardiogram and cardiac magnetic resonance revealed left ventricular apical hypertrophy suggestive of apical variant of HCM. A cardiac defibrillator was implanted for secondary prevention of SCD. After 6 months of follow-up no further rhythmic events were noted. DISCUSSION: Although low, the risk of SCD of ApHCM patients is not negligible. This case illustrates the need for searching of new predictors of rhythmic risk in patients with ApHCM.
format Online
Article
Text
id pubmed-7649509
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-76495092020-11-16 Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report Files Flores, Rui Mané, Fernando Antunes, Nuno Pereira, Vítor Hugo Eur Heart J Case Rep Case Reports BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a genetically determined myocardial disease that constitutes the main cause of sudden cardiac death (SCD) in young athletes. Apical HCM (ApHCM) represents a complex subset of patients, whose risk of SCD seems not negligible. Most applied scores likely underestimate the risk of heart events in this subset of patients. CASE SUMMARY: We report the case of a 55-year-old man who was admitted in the emergency department after an episode of aborted sudden death due to ventricular fibrillation. The electrocardiogram made at admission was noted for atrial fibrillation and a new-onset left bundle branch block. Emergency coronary angiography was normal. The electrocardiogram was repeated and showed symmetrical and profound inversion of T waves in the lateral leads. Transthoracic echocardiogram and cardiac magnetic resonance revealed left ventricular apical hypertrophy suggestive of apical variant of HCM. A cardiac defibrillator was implanted for secondary prevention of SCD. After 6 months of follow-up no further rhythmic events were noted. DISCUSSION: Although low, the risk of SCD of ApHCM patients is not negligible. This case illustrates the need for searching of new predictors of rhythmic risk in patients with ApHCM. Oxford University Press 2020-09-23 /pmc/articles/PMC7649509/ /pubmed/33204988 http://dx.doi.org/10.1093/ehjcr/ytaa316 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Reports
Files Flores, Rui
Mané, Fernando
Antunes, Nuno
Pereira, Vítor Hugo
Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report
title Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report
title_full Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report
title_fullStr Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report
title_full_unstemmed Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report
title_short Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report
title_sort apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649509/
https://www.ncbi.nlm.nih.gov/pubmed/33204988
http://dx.doi.org/10.1093/ehjcr/ytaa316
work_keys_str_mv AT filesfloresrui apicalhypertrophiccardiomyopathyarelowriskpatientsreallyatlowriskacasereport
AT manefernando apicalhypertrophiccardiomyopathyarelowriskpatientsreallyatlowriskacasereport
AT antunesnuno apicalhypertrophiccardiomyopathyarelowriskpatientsreallyatlowriskacasereport
AT pereiravitorhugo apicalhypertrophiccardiomyopathyarelowriskpatientsreallyatlowriskacasereport